NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | - | - | - | - |
What is the latest Capital Work in Progress ratio of NATH BIOGENES (INDIA) ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2013 | - |
How is Capital Work in Progress of NATH BIOGENES (INDIA) Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2013 | - | - | |
Compare Capital Work in Progress of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹306.4 Cr | 5.3% | 6.9% | -18% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,975.5 Cr | -1.8% | 1.4% | -13.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,017.9 Cr | 2.5% | -2.6% | 13.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,084.9 Cr | 2.1% | 8.5% | -20.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,192.1 Cr | 14.4% | 4% | -33.4% | Stock Analytics | |
| INDO US BIOTECH | ₹242.4 Cr | 1.3% | 9.6% | -64.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 5.3% |
6.9% |
-18% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses